Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery.

Schlesinger, Erica B; Bernards, Daniel A; Chen, Hunter H; Feindt, James; Cao, Jingtai; Dix, Daniel; Romano, Carmelo; Bhisitkul, Robert B; Desai, Tejal A

Schlesinger, Erica B; Bernards, Daniel A; Chen, Hunter H; Feindt, James; Cao, Jingtai; Dix, Daniel; Romano, Carmelo; Bhisitkul, Robert B; Desai, Tejal A.

Afiliação

Schlesinger EB; Graduate Program in Bioengineering University of California San Francisco CA 94158.
Bernards DA; Formulation Development Group Regeneron Pharmaceuticals Tarrytown NY 10591.
Chen HH; Dept. of Bioengineering and Therapeutic Sciences University of California San Francisco CA 94158.
Feindt J; Formulation Development Group Regeneron Pharmaceuticals Tarrytown NY 10591.
Cao J; Formulation Development Group Regeneron Pharmaceuticals Tarrytown NY 10591.
Dix D; Ophthalmology Research Regeneron Pharmaceuticals Tarrytown NY 10591.
Romano C; Formulation Development Group Regeneron Pharmaceuticals Tarrytown NY 10591.
Bhisitkul RB; Ophthalmology Research Regeneron Pharmaceuticals Tarrytown NY 10591.
Desai TA; Dept. of Ophthalmology University of California San Francisco CA 94158.

Bioeng Transl Med ; 4(1): 152-163, 2019 Jan.

Article em En | MEDLINE | ID: mdl-30680326

Palavras-chave

drug delivery; intravitreal device; polycaprolactone; protein formulation; sustained delivery; thin film device

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Bioeng Transl Med Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google